The global Computer Aided Detection (CAD) market was valued at US$621.4 million in 2019 and is projected to reach US$1,405.2 million by 2027, expanding at a CAGR of 10.7% between 2019 and 2027. Computer Aided Detection has become an established clinical technology designed to support physicians in detecting and diagnosing cancer, cardiovascular conditions, neurological diseases, and other abnormalities. CAD systems analyze medical images and assist clinicians by highlighting suspicious findings, reducing the risk of missed lesions, supporting earlier disease detection, and improving consistency between and among image readers. The technology can also function as a second-review tool, helping physicians evaluate diagnostic findings and identify potentially malignant lesions that may require further investigation. Growing adoption of advanced medical imaging, increasing disease burden, rising healthcare expenditure, and continuing investments in diagnostic technologies are contributing to market expansion.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1442

Market Size and Growth

The market's projected growth reflects increasing demand for technologies that can improve diagnostic workflows while supporting radiologists and other medical professionals. The development of sophisticated image-processing algorithms, expanding use of digital imaging, and improvements in artificial intelligence and machine-learning technologies are creating new opportunities for CAD solutions. Healthcare providers are increasingly focused on early diagnosis and efficient interpretation of large volumes of medical images, particularly in oncology. As imaging technologies such as mammography, magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and tomosynthesis become more widely deployed, the need for software-based detection and decision-support capabilities is also expected to increase. Research and development activities aimed at improving CAD sensitivity, specificity, workflow integration, and clinical usability are likely to remain important growth factors throughout the forecast period.

Market Segmentation

The Computer Aided Detection market is broadly segmented by application, imaging modality, and geography. By application, the market includes oncology, cardiovascular indications, and neurological indications, with oncology representing a major application area. Increasing awareness of cancer screening, greater emphasis on early diagnosis, and technological advances in medical imaging have supported demand for CAD applications in oncology. By imaging modality, the market is segmented into mammography, MRI, ultrasound, tomosynthesis, CT, and other modalities. Mammography has historically represented an important CAD application because of its established role in breast cancer screening and the longstanding use of computer-assisted analysis for breast imaging. Growing demand for breast cancer screening, increasing installations of CAD systems in large hospitals, and broader research into automated image interpretation continue to support opportunities across imaging modalities.

Regional Analysis

North America accounted for a leading share of the global CAD market in the historical period, supported by advanced healthcare infrastructure, high adoption of medical imaging technologies, and growing demand for breast cancer detection solutions. The region's established diagnostic ecosystem has also encouraged the expansion of CAD applications beyond mammography into other areas of oncology and disease detection. Europe has similarly witnessed adoption of CAD technologies, particularly in breast cancer imaging, supported by healthcare modernization and increasing awareness of early disease detection. Meanwhile, emerging healthcare markets in Asia Pacific and other regions present opportunities as hospitals expand diagnostic imaging capacity, healthcare investments increase, and demand for technologically advanced diagnostic tools grows.

Competitive Landscape

The competitive landscape includes established medical technology and healthcare companies offering imaging, diagnostic, and CAD-related solutions. Key participants identified in the market include Agfa-Gevaert N.V., iCAD, Inc., Hologic, Inc., GE Healthcare Ltd., Invivo Corporation, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems Corp., and McKesson Corporation. Competition is shaped by product development, imaging compatibility, clinical performance, workflow integration, technological innovation, and the ability to support healthcare providers across different diagnostic applications. Companies are also positioned to benefit from advances in artificial intelligence, automated image analysis, and integration of CAD capabilities into broader medical imaging platforms.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453